BRAF and colorectal carcinoma: Cells that were sensitive arrested in G(1) and/or underwent apoptosis and the presence of BRAF or KRAS mutation was not sufficient to predict either fate; however, CRC cells that did not harbor any mutation tended to be resistant [30].